Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Amorphical Ltd. manages a company patent portfolio in the Chemistry & Materials technology area. The portfolio currently features 2 pending office actions, which are distributed across 2 distinct art units. This indicates a technical focus within the chemistry field across multiple units. The 2 pending office actions are being handled by 2 distinct examiners, meaning the company is managing two separate dialogues with the patent office.
PHAN, ANNETTE HOANG-ANH is identified as the busiest examiner, although they are responsible for 1 busiest examiner pending action. This shows that the workload is evenly split between the 2 distinct examiners. With 2 distinct art units involved, the company must ensure consistency in its prosecution strategy across different technical groups. The presence of 2 pending office actions suggests an active level of engagement with the patent office in the Chemistry & Materials sector. For a practitioner, this distribution across 2 distinct examiners and 2 distinct art units means that the company's patent trajectory is less vulnerable to the specific tendencies of any single examiner. The 2 pending office actions serve as the primary focus of the company's current intellectual property efforts.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PHAN, ANNETTE HOANG-ANH | 1 | 71.7% | +9.8% |
| HELM, CARALYNNE E | 1 | 28.9% | +49.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17909549 | AMORPHOUS CALCIUM CARBONATE FOR TREATMENT OF ACIDOSIS | HELM, CARALYNNE E | 12d |
| 18227077 | PARTICLES COMPRISING AMORPHOUS DIVALENT METAL CARBONATE | PHAN, ANNETTE HOANG-ANH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17909549 | AMORPHOUS CALCIUM CARBONATE FOR TREATMENT OF ACIDOSIS | HELM, CARALYNNE E | 12d |
| Art Unit | Apps |
|---|---|
| 1736 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18227077 | PARTICLES COMPRISING AMORPHOUS DIVALENT METAL CARBONATE | PHAN, ANNETTE HOANG-ANH | 1736 | §102§103 | Non-Final OA | — | Pending | Jul 27, 2023 |
| 17909549 | AMORPHOUS CALCIUM CARBONATE FOR TREATMENT OF ACIDOSIS | HELM, CARALYNNE E | 1615 | §103§112 | Final Rejection | 12d | Pending | Sep 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAmorphical Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Annette Hoang-Anh Phan has the most, with 1 of Amorphical Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
